Quality of Life and Cognitive Functioning in Patients With Glial Tumors

Quality of Life and Cognitive Functioning as Prognostic Factor in Glial Tumours

The aim of this study is to introduce appropriate assessment instruments and to define patients with gliomas according to cognitive functioning and quality of life. The study will evaluate cognitive functioning as a prognostic factor for survival in patients with glial tumors and will support optimization of treatment strategies to improve patients' quality of life.

This prospective cohort study will assess cognitive functioning and quality of life in patients with glial tumors. The objective is to determine the prognostic value of cognitive functioning on survival, establish appropriate assessment instruments, and contribute to treatment adaptation with the goal of improving quality of life in these patients.

Inclusion Criteria:

• Adult participants (≥18 years)
• Patients with histologically confirmed glial tumour
• Ability to understand the study procedures and provide written informed consent
• Ability to complete quality of life questionnaires and cognitive testing

Exclusion Criteria:

• Age <18 years
• Inability to provide informed consent
• Severe cognitive impairment or clinical condition preventing completion of questionnaires and cognitive testing
• Insufficient language proficiency to complete the questionnaires and neuropsychological testing